Dogwood Therapeutics, Inc. , a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response.
Dogwood Therapeutics stock last closed at $4.79, up 3.01% from the previous day, and has decreased 23.36% in one year. It has overperformed other stocks in the Biotechnology industry by 0.5 percentage points. Dogwood Therapeutics stock is currently +195.68% from its 52-week low of $1.62, and -83.64% from its 52-week high of $29.28.
As of Jun 16, 2025, there are 1.91M shares of DWTX outstanding. The market cap of DWTX is $9.15M. In the past 24 hours, 19,600 DWTX shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy DWTX stock.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, it's time to fill out some personal info so you are able to invest in DWTX stock today.
Now that you have filled out your info on our top ranked stock app, you can securely and quickly fund your account:
Check out the walkthrough below to see the process of transferring funds into your investment account.
Once you have identified the best place to buy Dogwood Therapeutics stock, it's absolutely critical to analyze their stock before you invest, so you truly comprehend the risk as well as the upside.
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on DWTX's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge DWTX's true value.
Using relative valuations methods:
You can do additional valuation research on DWTX's stock here.
Out of 1 sell side analysts who research DWTX, the consensus analyst rating on Dogwood Therapeutics is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Dogwood Therapeutics stock forecast page.
Over the past year, executives and large shareholders at DWTX have not bought or sold any shares.
Research more about who owns DWTX stock here.
No, Dogwood Therapeutics doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
There are two primary types of orders:
Hit the Open button and eToro will execute the order.
If you need more info about investing in stocks on eToro, watch the how to video below:
Now that you own some DWTX stock, you'll want to stay up-to-date on your company.
Put DWTX on a watchlist to see the latest developments about your DWTX stock.
To summarize, here are the 6 steps for buying Dogwood Therapeutics stock:
If you are looking for a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get updates on your investment in Dogwood Therapeutics, add DWTX to your watchlist below.